Chemoinformaics analysis of 6beta-Hydroxyhyoscyamine
| Molecular Weight | 305.374 | nRot | 4 |
| Heavy Atom Molecular Weight | 282.19 | nRig | 16 |
| Exact Molecular Weight | 305.163 | nRing | 3 |
| Solubility: LogS | -1.65 | nHRing | 2 |
| Solubility: LogP | 1.118 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 48.0342 |
| nHD | 2 | BPOL | 27.3878 |
| QED | 0.809 |
| Synth | 4.467 |
| Natural Product Likeliness | 1.624 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.549 |
| HIA | 0.022 |
| CACO-2 | -5.15 |
| MDCK | 0.000282752 |
| BBB | 0.165 |
| PPB | 0.1794 |
| VDSS | 2.208 |
| FU | 0.7963 |
| CYP1A2-inh | 0.017 |
| CYP1A2-sub | 0.064 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.792 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.214 |
| CYP2d6-inh | 0.22 |
| CYP2d6-sub | 0.607 |
| CYP3a4-inh | 0.067 |
| CYP3a4-sub | 0.651 |
| CL | 9.536 |
| T12 | 0.293 |
| hERG | 0.25 |
| Ames | 0.044 |
| ROA | 0.03 |
| SkinSen | 0.497 |
| Carcinogencity | 0.255 |
| EI | 0.012 |
| Respiratory | 0.867 |
| NR-Aromatase | 0.001 |
| Antiviral | Yes |
| Prediction | 0.805406 |